维普期刊资源整合服务平台（V6.5）

维普中文期刊产品整合服务

14篇 您的检索式：作者名="Pavanato"

选中清除导出查看参考文献查看引证文献引用追踪共1页首页上一页第1页下一页末页 /1 跳转

		题名	作者	年代	出处	被引量
	1	Radiotherapy for non-small cell lung cancer in patients aged 75 and over,safety,effectiveness and possible impact on survival显示文摘	LONARDI F COELI M PAVANATO G	2000	Lung Cancer2000，28，1：	1
	2	Effects of quercetin on liver damage in rats with carbon tetrachlorideinduced cirrhosis显示文摘	Pavanato A Tunon M J Sanchez-Campos S	2003	Dig Dis Sci2003，48，4：	1
	3	Radiotherapy for non-small cell lung cancer in patients aged 75 and over safety and effectiveness and possible impact on survival 显示文摘	Lonardi F Cocli M Pavanato G	2000	Lung Cancer2000，28，：	1
	4	Effects of quercetin on liver damage in rats with carbon tetrachloride induced cirrhosis显示文摘	Pavanato A Tunon MJ Sancher - campos S	2003	Dig Dis Sci2003，48，4：	1
	5	Effects of quercetin on liver damage in rats with carbon tetrachloride-induced cirrhosis显示文摘	Pavanato A Tunon MJ Sanchez-Campos S	2003	Dig Dis Sci2003，48，4：	1
	6	Effects of quercetin on liver damage in rats with carbon tetrachloride - induced cirrhosis显示文摘	Pavanato A Tunon M J Sanchez - Campos S	2003	Dig Dis Sci2003，48，4：	1
	7	Effects of quercetin on liver damage in rats with carbon tetrachloride induced cirrhosis 显示文摘	Pavanato A Tunon MJ Sancher_campos S	2003	Dig Dis Sci2003，48，4：	1
	8	Hepatoprotective effects of pecan nut shells on ethanol-induced liver damage 显示文摘	Miiller L G Pase C S Reckziegel P Barcelos R C Boufleur N Prado A C Fett R Block J M Pavanato M A Bauermann L F da Rocha J B Burger iV/E	2013	Experimental and Toxicologic Pathology: Official2013，65，12：	1
	9	Neurotoxicity after chemotherapy with vinorelbine显示文摘	Lonardi F Pavanato G Ferrari V	1993	Eur J Cancer1993，29，12：	1
	10	Radiotherapy for non-small cell lung cancer in patients aged 75 and over:safety,effectiveness and possible impact on survival显示文摘	Lonardi F Coeli M Pavanato G	2000	Lung Cancer2000，28，1：	1
	11	Effects of quercetin on liver damage in rats with carbon tetrachloride-indueed cirrhosis显示文摘	Pavanato A Tufi6n MJ Sinchez-Campos S	2003	Dig Dis Sci2003，48，4：	1
	12	Effect of quereetion on liver damage in rats with carbon tetraehloride-induced cirrhosis显示文摘	PAVANATO A TUNON M J SANEHEZ-CAMPOS S	2003	Dig Dis Sci2003，48，4：	1
	13	Effects of Quercetin on Liver Damage in Rats with Carbon Tetrachloride-Induced Cirrhosis显示文摘	Amalia Pavanato María J. Tu?ón Sonia Sánchez-Campos Claudio A. Marroni Susana Llesuy Javier González-Gallego Norma Marroni	2003	Digestive Diseases and Sciences2003，，4：	1
	14	Azathioprine monotherapy withdrawal in inflammatory bowel diseases: A retrospective mono-centric study显示文摘BACKGROUND There is no consensus on the recommended duration of and optimal time to stop azathioprine(AZA)therapy in inflammatory bowel disease(IBD).Determining the optimal duration and cessation time can help to balance the risks of long-term intake with the possibility of relapse after cessation.AIM To describe the events following AZA cessation.METHODS Retrospective analysis was performed to examine data from adult patients affected by IBD who were followed at the University of Padua and had started but then discontinued AZA between 1995 and 2022.Data on therapy duration,reasons for cessation,and type of relapse after cessation were collected.Cox regression models were used to estimate the risk of relapse in different subgroups.RESULTS A total of 133 ulcerative colitis patients and 141 Crohn’s disease patients were included.Therapy with AZA was stopped in the 1st year in approximately 34%of patients but was continued for more than 10 years in approximately 10%of cases.AZA discontinuation was due to primary failure or disease relapse in 30%of patients and due to disease remission in 25.2%of patients.Most of the remaining cases stopped AZA therapy due to side effects(primarily clinical intolerance,cytopenia,and pancreatic disease).Patients who stopped AZA for clinical remission had an 83%lower risk of relapse during the observation time than other groups,with a relapse-free rate of 89%after 1 year and 79%after 2 years.CONCLUSION AZA administration is effective and safe,but it requires careful monitoring for potential minor and major side effects.Only 10%of patients who achieved remission with AZA needed a new treatment within 1 year of drug interruption.	Martina Crepaldi Daria Maniero Alessandro Massano Margherita Pavanato Brigida Barberio Edoardo Vincenzo Savarino Fabiana Zingone	2023	World Journal of Gastroenterology2023，29，27：	0

返回顶部每页显示：

共1页首页上一页第1页下一页末页 /1 跳转

goolge学术搜索-维普

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1　渝公网安备 50019002500403号　违法和不良信息举报中心

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费